EP 1239866 A4 20050209 - INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
Title (en)
INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
Title (de)
INDUZIERUNG VON ZELLULÄRER IMMUNANTWORT AUF HER2/NEU MIT HILFE VON PEPTID- UND NEUKLEINSÄUREZUBEREITUNGEN
Title (fr)
INDUCTION DE REPONSES IMMUNES CELLULAIRES A HER2/NEU A L'AIDE DE COMPOSITIONS RENFERMANT DES PEPTIDES ET DES ACIDES NUCLEIQUES
Publication
Application
Priority
- US 0033591 W 20001211
- US 45829999 A 19991210
Abstract (en)
[origin: WO0141787A1] This invention uses our knoeledge of the mechanisms by which antigen is recognized by T cells to identify and prepare HER2/neu epitopes, and to develop epitope-based vaccines directed towards HERS2/neu-bearing tumors. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of cancer.
IPC 1-7
A61K 38/00; A61K 38/03; A61K 38/08; A61K 38/10; A61K 38/16; C07K 7/00; C07K 9/00; C07K 14/435; C07H 21/02; C07H 21/04
IPC 8 full level
C12N 15/09 (2006.01); A61K 38/03 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61P 35/00 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01); C07K 14/705 (2006.01); C07K 14/71 (2006.01); C07K 14/725 (2006.01); C12N 5/10 (2006.01)
CPC (source: EP US)
A61K 39/001106 (2018.08 - EP US); A61P 35/00 (2018.01 - EP); C07K 14/71 (2013.01 - EP); A61K 39/00 (2013.01 - EP); A61K 2039/5154 (2013.01 - EP); A61K 2039/605 (2013.01 - EP)
Citation (search report)
- [X] WO 9403205 A1 19940217 - CYTEL CORP [US]
- [X] WO 9945954 A1 19990916 - EPIMMUNE INC [US]
- [A] KONO KOJI ET AL: "Identification of HER2/neu-derived peptide epitopes recognized by gastric cancer-specific cytotoxic T lymphocytes", INTERNATIONAL JOURNAL OF CANCER, vol. 78, no. 2, 5 October 1998 (1998-10-05), pages 202 - 208, XP002280379, ISSN: 0020-7136
- [A] FISK BRYAN ET AL: "Identification of an Immunodominant Peptide of HER-2/neu Protooncogene Recognized by Ovarian Tumor-specific Cytotoxic T Lymphocyte Lines", JOURNAL OF EXPERIMENTAL MEDICINE, vol. 181, no. 6, 1995, pages 2109 - 2117, XP009030958, ISSN: 0022-1007
- See also references of WO 0141787A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0141787 A1 20010614; AU 2087401 A 20010618; CA 2393738 A1 20010614; EP 1239866 A1 20020918; EP 1239866 A4 20050209; EP 1568373 A2 20050831; EP 1568373 A3 20051221; JP 2003530083 A 20031014
DOCDB simple family (application)
US 0033591 W 20001211; AU 2087401 A 20001211; CA 2393738 A 20001211; EP 00984214 A 20001211; EP 05008363 A 20001211; JP 2001543131 A 20001211